4-[(4-Bromophenyl)sulfanyl]-2-{[(3,4-dichlorophenyl)methyl]sulfanyl}-5-methoxypyrimidine

Catalog No. :
ACNIVH038
CAS No. :
339276-02-7
Molecular Formula :
C18H13BrCl2N2OS2
Molecular Weight :
488.26

IUPAC Name:4-((4-bromophenyl)thio)-2-((3,4-dichlorobenzyl)thio)-5-methoxypyrimidine

4-[(4-Bromophenyl)sulfanyl]-2-{[(3,4-dichlorophenyl)methyl]sulfanyl}-5-methoxypyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$325.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-[(4-Bromophenyl)sulfanyl]-2-{[(3,4-dichlorophenyl)methyl]sulfanyl}-5-methoxypyrimidine
IUPAC Name4-((4-bromophenyl)thio)-2-((3,4-dichlorobenzyl)thio)-5-methoxypyrimidine
Molecular FormulaC18H13BrCl2N2OS2
Molecular Weight488.26
SMILESCOC1=CN=C(SCC2=CC=C(Cl)C(Cl)=C2)N=C1SC3=CC=C(Br)C=C3
InChI KeyJUZWZSTXVNQKEG-UHFFFAOYSA-N
Synonym4-[(4-BROMOPHENYL)SULFANYL]-2-[(3,4-DICHLOROBENZYL)SULFANYL]-5-METHOXYPYRIMIDINE;4-[(4-BROMOPHENYL)SULFANYL]-2-[(3,4-DICHLOROBENZYL)SULFANYL]-5-PYRIMIDINYL METHYL ETHER;4-[(4-bromophenyl)sulfanyl]-2-{[(3,4-dichlorophenyl)methyl]sulfanyl}-5-methoxypyrimidine;Pyrimidine, 4-[(4-bromophenyl)thio]-2-[[(3,4-dichlorophenyl)methyl]thio]-5-methoxy-
CAS No.339276-02-7

Synthetic Route by SureRoute

1. ACNIVH038 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNIVH038 route product structure diagram
    ACNIVH038339276-02-7
Inquiry

2. ACNIVH038 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNIVH038 route product structure diagram
    ACNIVH038339276-02-7
Inquiry

Comments (0)